[Corrigendum] Nucleosomebinding protein HMGN2 exhibits antitumor activity in human SaO2 and U2OS osteosarcoma cell

Guojun Liang1, Enjie Xu2, Chaoqun Yang2

  • 1Department of Spine Surgery, Xinchang People's Hospital, Xinchang, Zhejiang 312500, P.R. China.

Oncology Reports
|October 18, 2024
PubMed

Insights

This corrigendum addresses image and data duplication errors in figures concerning xenograft tumor experiments. Corrected figures are provided, ensuring no impact on the study's overall conclusions regarding GFP/U2-OS and SaO2 experiments.

Area of Science:

  • Oncology Research
  • Experimental Pathology
  • Biomedical Imaging

Context:

  • The original study investigated xenograft tumor growth and response to specific experimental conditions.
  • Concerns were raised regarding the accurate representation of experimental data in published figures.

Purpose:

  • To correct errors in figure assembly identified post-publication.
  • To ensure the integrity and accurate depiction of experimental results.

Summary:

  • Identified instances of duplicated xenograft tumor images in Fig. 5A and similar data sets for distinct experiments in Fig. 4A.
  • Corrected figures include revised images and data, along with corrected labels (e.g., 'Tumor weight' instead of 'Tumor volume').
  • An omitted experimental result from Fig. 5A has been included, and incorrect data for the 'SaO2/GFP/24 h' experiment was replaced.

Impact:

  • The corrigendum rectifies data presentation issues without altering the fundamental conclusions of the original research.
  • Ensures clarity and accuracy for readers and future research referencing the study.
  • Upholds scientific integrity by addressing and correcting errors in published data.